ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Heidelberger Wins $100,000 Award

September 17, 1982

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987